Intelligent Medicine Acquisition Corp.

Annual Report for period ending 2022-12-31

Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT for period ending 2022-12-31

Quarterly Report for period ending 2022-09-30

Quarterly Report for period ending 2022-06-30

Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending 2022-03-31

Quarterly Report for period ending 2022-03-31

Annual Report for period ending 2021-12-31

Quarterly Report for period ending 2021-09-30

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Notice of termination of registration of a class of securities under Section 12(g)

Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

Certification by an exchange approving securities for listing

Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)

Notice of Effectiveness

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

CALAMOS INVESTMENT TRUST/IL: Major Shareholders

GOLDMAN SACHS & CO. LLC: Initial statement of beneficial ownership of securities

Saba Capital Management, L.P.: Major Shareholders

Saba Capital Management, L.P.: Statement of changes in beneficial ownership of securities

Intelligent Medicine Sponsor LLC: Major Shareholders

Intelligent Medicine Sponsor LLC: Statement of changes in beneficial ownership of securities

Saba Capital Management, L.P.: Initial statement of beneficial ownership of securities

Saba Capital Management, L.P.: Initial statement of beneficial ownership of securities

Saba Capital Management, L.P.: Major Shareholders

Saba Capital Management, L.P.: Major Shareholders

Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Prospectus filed pursuant to Rule 424(b)(4)

A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S-1

General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy

Correspondence Related to Draft Registration Statement

Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

Definitive proxy statements

Preliminary proxy statement not related to a contested matter or merger/acquisition